According to the authors, this mechanism could be linked to BCL-2’s modulatory effects on cancer cell proliferation and the coexistence of other BCL-2 family proteins, such as Bax, which may counterbalance BCL-2’s effect [150]. This evidence concerns the gene BCL2 and cancer.